(4-Methoxy-benzenesulfonylamino)-acetic acid, 95.0%, 5g

(4R)-2-(4-Fluorophenyl)thiazolidine-4-carboxylic acid, 95.0%, 5g

3-(4-FLUOROPHENOXY)PIPERIDINE HCL, 95.0%, 250mg

Ethyl 5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-2-carboxylate, 98%, 1g

3-Azetidineacetic acid ethyl ester hydrochloride, 95.0%, 100mg

2-Chloro-5-(trifluoromethyl)benzoic acid, 98.0%, 10g

2-Chloro-4-nitrobenzamide, 98.0%, 1g

1,6-Hexanediol, >=96%, for synthesis, 2.5 kg, plastic packaging.

3-Amino-2-methylbenzoic Acid>99.0%(HPLC)(T)250g

1,2,4,5-Tetrafluorobenzene, 99.0%, 10g

2-Acetyl-5-iodothiophene, 97.0%, 10g

2-Cyclohexyl-D-glycine, 97.0%, 10g

Capillary pipettes without heparinization, 60 µl, 1000 pieces